CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 14 enrolled
Drug / intervention
CDI 1000 COMdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00598819
NCT00598819Phase 1Completed
CompareCT.gov

A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Healthy Volunteers

University of California, Irvine·interventional·Posted Jan 23, 2008·Updated Aug 17, 2011

In Brief

A Phase 1 clinical trial evaluating CDI 1000 COM for Cerebral Ischemia. Completed, enrolled 14 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether a new cerebral oxygen monitoring device is effective and comparatively similar to the current approved devices.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Ischemia
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 23, 2008
Enrollment StartOct 1, 2007
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 18.4 years ago

Interventions

CDI 1000 COMdevice

CDI 1000 COM sensors were attached to subject's forehead for a 12 hour period.